EP2310365A1 - Procédé de fabrication de sels de n-phényl-n-(4-pipéridinyl)amide - Google Patents
Procédé de fabrication de sels de n-phényl-n-(4-pipéridinyl)amideInfo
- Publication number
- EP2310365A1 EP2310365A1 EP08773829A EP08773829A EP2310365A1 EP 2310365 A1 EP2310365 A1 EP 2310365A1 EP 08773829 A EP08773829 A EP 08773829A EP 08773829 A EP08773829 A EP 08773829A EP 2310365 A1 EP2310365 A1 EP 2310365A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- compound
- formula
- iii
- alkyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Definitions
- the present invention relates to the production of amide salts being selected ⁇ N-phenyl-N- (4-piperidinyl), particularly of salts of the compound remifentanil, in particular of remifentanil hydrochloride.
- Remifentanil corresponds to the compound of formula (I) wherein R is methyl and R x is ethyl.
- Compounds of the formula (I) are synthetic opiods which are used as anesthetics.
- a preferred method of preparing the salts of compounds of formula (I) is to alkylate a compound of formula (II) by means of an aza-Michael addition and the resulting compound of formula (I) to a pharmaceutically acceptable salt, preferably
- the process according to the invention proceeds without the addition of a catalyst, it being possible to add a catalytic amount of a catalyst, for example a base, to the reaction mixture in order to accelerate the reaction.
- a catalyst for example a base
- the pure compound of the formula (I) can subsequently be obtained from the salt in a manner known per se.
- R is independently lower alkyl, preferably (CI_ 4) -alkyl, preferably methyl or ethyl, preferably methyl;
- Ri is lower alkyl, preferably (CI_ 4) -alkyl, preferably methyl or ethyl, preferably ethyl; and
- HX is an inorganic or organic acid, preferably hydrogen halide, preferably HBr, HJ, HCl, preferably HCl; or an organic mono- or dicarboxylic acid, preferably ⁇ as oxalic acid; in which the components are reacted, if appropriate, in the presence of a catalyst, preferably at elevated temperature, and then the reaction mixture is allowed to cool, the salt of the compound of the formula (I) being obtained.
- the present invention also relates to the salts of the compound of the formula (I) prepared according to the invention, which are obtained directly in crystalline or amorphous form.
- the present invention also relates to a process for the preparation of the free base of the compound of the formula (I) which comprises reacting a salt prepared according to the invention of the compound of the formula (I) in a manner known per se into the compound of the formula (I) transforms.
- R methyl
- R 1 ethyl
- HX HCl.
- An important advantage of the process according to the invention is that the compound of the formula (III) is present as a crystalline or amorphous solid and leads to the end product in a single step.
- a suitable inert solvent containing the acrylic acid ester in an amount of about 1 to 10 equivalents, calculated on the amount of the compound of formula (III).
- an alcohol such as methanol, ethanol, n-propanol, isopropanol, butanol
- an ether for example tert. butyl methyl ether; or tetrahydrofuran (THF); or acetonitrile; or another compound suitable as a solvent or a mixture of these compounds.
- THF tetrahydrofuran
- Solvent or a mixture of such solvents can be readily optimized by the skilled person.
- the compound of the formula (III) is dissolved or suspended in an inert solvent or in a mixture of the inert solvents and these are at least an equimolar amount of Acrylsaurealkylester calculated on the molar amount of the compound of formula (III), and optionally also a catalyst, to.
- the acrylic acid ester is preferably used in an amount of about 1 to 10 equivalents, preferably in an amount of about 3 to 10 equivalents, preferably in an amount of about 3 to 6 equivalents, and more preferably in an amount of about 5 equivalents, calculated on the amount of the compound of the formula (III).
- the weight ratio of solvent to alkyl acrylate is preferably - -
- reaction mixture is stirred for a sufficient time at elevated temperature, wherein the compound of formula (I) precipitates immediately and / or upon cooling of the reaction mixture in crystalline or amorphous form and can be filtered off.
- the reaction mixture is treated at a temperature in the range of about 20-120 0 C, depending on the boiling point of the reaction mixture, preferably at a temperature in
- the formed salt of compound (I) usually precipitates immediately or upon cooling of the reaction mixture in crystalline or amorphous form.
- the catalyst is added to the reaction mixture.
- a suitable catalyst significantly accelerates the reaction rate.
- Suitable catalysts are, for example, metal carbonates, e.g. Sodium carbonate, potassium carbonate, lithium carbonate, magnesium carbonate, calcium carbonate; tertiary amines, e.g. Triethylamine, N-methylmorpholine, Hunig's base (ethyldiisopropylamine), N, N-dimethylbenzylamine; basic inorganic hydroxides, e.g. Alumina, calcium oxide, sodium hydroxide, potassium hydroxide, lithium hydroxide; basic ion exchangers, e.g. Amberlyst A21.
- metal carbonates e.g. Sodium carbonate, potassium carbonate, lithium carbonate, magnesium carbonate, calcium carbonate
- tertiary amines e.g. Triethylamine, N-methylmorpholine, Hunig's base (ethyldiisopropylamine),
- the concentration of the catalyst for example the tertiary amine, is preferably in the range of 1-10 mol%, preferably about 3-5 mol%, per mole of the compound used of the formula (III).
- concentrations for the other catalysts mentioned above are readily determinable by those skilled in the art.
- the moist product as a crude product is preferably dissolved in an organic solvent in the heat and crystallized by the addition of an antisolvent. As a rule, this gives a product with a purity of more than 99.5%.
- the moist product remifentanil crude (8.333 g) is taken up in methanol (25 ml), heated to boiling (Ih) and subjected to a clear filtration. After cooling to RT tert. Butyl methyl ether (12.5 ml) was added. The suspension is cooled to 0-5 0 C and stirred for Ih at this temperature. The precipitate is filtered off, with tert. -Butylmethylether (25 ml) and the moist product dried in vacuo (50 0 C, 18h). This gives 7.648 g (74%) dry product Remifentanil API as a colorless solid; Purity> 99.5%.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention porte sur un procédé de fabrication de sels de N-phényl-N-(4-pipéridinyl)amide, en particulier de sels d'addition pharmaceutiquement compatibles du composé Rémifentanil. Selon ce procédé, on fait réagir un composé de formule (III) avec un ester alkylique d'acide acrylique de formule CH2=CH-C(O)-OR : où les R représentent indépendamment l'un de l'autre alkyle de masse moléculaire inférieure, de préférence alkyle en C1-4, de préférence méthyle ou éthyle, R1 représente alkyle de faible masse moléculaire, de préférence alkyle en C1-4, de préférence méthyle ou éthyle; et HX représente un acide inorganique ou organique, en faisant réagir les composants le cas échéant en présence d'un catalyseur, de préférence à une température élevée, ce par quoi le sel du composé de formule (I) est obtenu.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2008/005418 WO2010000282A1 (fr) | 2008-07-03 | 2008-07-03 | Procédé de fabrication de sels de n-phényl-n-(4-pipéridinyl)amide |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2310365A1 true EP2310365A1 (fr) | 2011-04-20 |
Family
ID=40600169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08773829A Withdrawn EP2310365A1 (fr) | 2008-07-03 | 2008-07-03 | Procédé de fabrication de sels de n-phényl-n-(4-pipéridinyl)amide |
Country Status (4)
Country | Link |
---|---|
US (1) | US20110144346A1 (fr) |
EP (1) | EP2310365A1 (fr) |
JP (1) | JP2011526257A (fr) |
WO (1) | WO2010000282A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102617448B (zh) * | 2012-03-13 | 2014-10-15 | 四川大学华西医院 | 4-甲氧甲基-4-(n-丙酰基)苯胺哌啶类化合物、制备方法及用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5019583A (en) * | 1989-02-15 | 1991-05-28 | Glaxo Inc. | N-phenyl-N-(4-piperidinyl)amides useful as analgesics |
ATE340159T1 (de) * | 1999-12-06 | 2006-10-15 | Mallinckrodt Inc | Verfahren zur herstellung von alfentanil, sufentanil und remifentanil |
EP1867635A1 (fr) * | 2006-06-15 | 2007-12-19 | Kern Pharma, S.L. | Procédé de préparation de remifentanil, ses produits intermédiaires, leur application et procédé pour leur préparation |
EP2081899A2 (fr) * | 2006-10-05 | 2009-07-29 | Mallinckrodt Inc. | Procédé alternatif pour la préparation du remifentanil |
-
2008
- 2008-07-03 US US13/002,376 patent/US20110144346A1/en not_active Abandoned
- 2008-07-03 JP JP2011515118A patent/JP2011526257A/ja active Pending
- 2008-07-03 WO PCT/EP2008/005418 patent/WO2010000282A1/fr active Application Filing
- 2008-07-03 EP EP08773829A patent/EP2310365A1/fr not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
See references of WO2010000282A1 * |
Also Published As
Publication number | Publication date |
---|---|
JP2011526257A (ja) | 2011-10-06 |
US20110144346A1 (en) | 2011-06-16 |
WO2010000282A1 (fr) | 2010-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE19933926A1 (de) | Biphenylderivate, ihre Herstellung und ihre Verwendung als Arzneimittel | |
EP1773801A1 (fr) | Procede de fabrication de tetrahydrocannabinol pur | |
EP2387556A1 (fr) | Séparation d'un mélange d'énantiomères de (r)- et de (s)-3-amino-1-butanol | |
FI117438B (fi) | Menetelmä optisesti rikastetun bupivakaiinin valmistamiseksi | |
EP1636199A2 (fr) | Procede de production de derives d'acide phenylacetique | |
EP1607090B1 (fr) | Asimadoline pour le traitement du syndrome du colon irritable | |
EP0110869A1 (fr) | Dérivés d'amide thiénylacétique, sels d'addition pharmaceutiquement acceptables et procédé pour leur préparation | |
EP2310365A1 (fr) | Procédé de fabrication de sels de n-phényl-n-(4-pipéridinyl)amide | |
US8680332B2 (en) | Disubstituted-aminodifluorosulfinium salts, process for preparing same and method of use as deoxofluorination reagents | |
EP2455377B1 (fr) | Synthèse d'analogues de fentanyl | |
EP0216324B1 (fr) | Ester d'acides 4-alkoxy-3-pyrrolin-2-one-1-yl-acétiques et leur préparation | |
DE60107292T2 (de) | Verfahren zur Herstellung von (+)-trans-4-p-Fluorophenyl-3-hydroxymethyl-1-methylpiperidin | |
DD292913A5 (de) | Verfahren zur herstellung neuer benzothiopyranylamine | |
EP2121679B1 (fr) | Procédé de production d'esters d'azoniaspironortropine | |
EP0362350A1 (fr) | Procede de production d'heteroaromates azotes a 5 membres | |
DE4432610C1 (de) | Verfahren zur Herstellung von Selegilin-Hydrochlorid | |
DD247217A5 (de) | Verfahren zur herstellung von 2,6,-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridin-3,5-dicarbonsaeure-3 beta (n-benzyl-n-methylamino)-ethylester-5-methylester und dessen hydrochlorid-salz | |
KR101653816B1 (ko) | 결정형 사포그릴레이트 옥살산염 일수화물 또는 이의 무수물 | |
US1550350A (en) | Alkaminesters of the p-aminobenzoic acids and process of making same | |
EP1373241B1 (fr) | Procede de production de dihydropyrones optiquement actives | |
WO2005049570A1 (fr) | Procede de synthese de piperidines optiquement actives par hydrogenation de pyridines optiquement actives | |
DE60308170T2 (de) | Verfahren zur herstellung von chinolinderivaten | |
AT360995B (de) | Verfahren zur herstellung neuer phenylazacyclo- alkane und von deren salzen und optisch aktiven verbindungen | |
JPH02304071A (ja) | 不飽和カルボン酸アミドの製造方法 | |
DE2624340A1 (de) | Verfahren zur herstellung von 1,1-dihalogen-1,3-dienen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20110203 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20130201 |